JESSE RUMBOUGH: Open Payments
NPI 1619371788 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 40 payments from 9 companies in 2025. Trend: 2023 $946 · 2024 $1,157 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $163 |
| E.R. Squibb & Sons, L.L.C. | 9 | $141 |
| Novartis Pharmaceuticals Corporation | 9 | $135 |
| Merck Sharp & Dohme LLC | 5 | $110 |
| PFIZER INC. | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Amgen Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $15 |
Products named: LifeVest, ELIQUIS, LEQVIO, CAMZYOS, VERQUVO, FARXIGA, Kerendia, ENTRESTO.
Industry payments across FL — which companies pay providers there.
